Monopoly is a huge factor in driving up prices and driving down quality in America’s health care sector. After waves of hospital mergers, most Americans now live in communities where only one or two hospitals still compete for their health care dollars, and where competition among health care insurers has also largely disappeared. Meanwhile, competition in the pharmaceutical industry is stymied by patent monopolies and highly concentrated corporate ownership.
Open Markets Institute filed an amicus brief to the Seventh Circuit Court in support of the plaintiffs in Marion Diagnostic Center v. Becton, Dickinson & Co. The plaintiffs, who are health care providers, allege that Becton, Dickinson & Co. illegally dominated the markets for conventional syringes, safety syringes, and safety IV catheters.
Welcome to The Corner. In this issue, we discuss why the FTC had to spend two years proving that it was illegal for a drug monopolist to pay off its competitor. And we share two new feature articles by Open Markets team.
Bristol-Myers Squibb Co. won shareholder approval for its $74 billion takeover of Celgene Corp., closing “the largest pharmaceutical merger in history”, according to Bloomberg. Open Markets calls on the Federal Trade Commission (FTC) to block this deal.
Welcome to The Corner. In this issue we point out the shortcomings of Apple CEO Tim Cook’s big plan to promote privacy and highlight one Republican congressman’s ambitious plan to counter hospitals’ monopoly power. We also share two feature articles by Open Markets in the new Washington Monthly on how fighting monopoly can help Democrats win the Senate, and on the secret anti-monopoly powers of the FTC.
Greetings from Open Markets. In this issue of The Corner, we address Trump’s attacks on Amazon, highlight an important new study that shows medical costs are higher in concentrated markets, and look at who really owns the data that Facebook collects. To read previous editions of The Corner, click here.